Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of duchenne muscular dystrophy
Author(s) -
Tero Puolakkainen,
Hongqiang Ma,
Arja Pasternack,
Heikki Kainulainen,
Olli Ritvos,
Kristiina Heikinheimo,
Juha J. Hulmi,
Riku Kiviranta
Publication year - 2013
Publication title -
bone abstracts
Language(s) - English
Resource type - Journals
ISSN - 2052-1219
DOI - 10.1530/boneabs.01.oc2.1
Subject(s) - duchenne muscular dystrophy , activin receptor , muscular dystrophy , key (lock) , bone mass , mdx mouse , medicine , endocrinology , anatomy , biology , transforming growth factor , dystrophin , osteoporosis , ecology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom